UCB SA (UCBJY)
91.57
+1.48
(+1.64%)
USD |
OTCM |
Sep 16, 15:36
UCB Price: 91.57 for Sept. 16, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 13, 2024 | 90.32 | 90.32 | 89.91 | 90.09 | 2182.00 |
| Sep 12, 2024 | 89.33 | 90.60 | 88.83 | 90.44 | 8526.00 |
| Sep 11, 2024 | 88.88 | 89.35 | 88.17 | 89.26 | 4797.00 |
| Sep 10, 2024 | 89.15 | 89.28 | 88.73 | 88.97 | 3239.00 |
| Sep 09, 2024 | 89.48 | 90.03 | 89.48 | 89.97 | 3144.00 |
| Sep 06, 2024 | 89.51 | 89.51 | 88.78 | 88.98 | 3340.00 |
| Sep 05, 2024 | 89.27 | 89.27 | 88.54 | 88.56 | 3235.00 |
| Sep 04, 2024 | 90.25 | 90.98 | 89.87 | 90.93 | 4605.00 |
| Sep 03, 2024 | 89.16 | 89.16 | 88.86 | 88.93 | 1881.00 |
| Aug 30, 2024 | 90.91 | 90.94 | 90.45 | 90.72 | 9219.00 |
| Aug 29, 2024 | 90.59 | 91.05 | 90.25 | 90.93 | 3857.00 |
| Aug 28, 2024 | 90.12 | 90.26 | 89.85 | 90.05 | 2858.00 |
| Aug 27, 2024 | 88.41 | 90.60 | 88.41 | 90.51 | 4136.00 |
| Aug 26, 2024 | 90.32 | 90.32 | 90.10 | 90.10 | 2080.00 |
| Aug 23, 2024 | 89.92 | 90.17 | 89.71 | 90.03 | 2406.00 |
| Aug 22, 2024 | 89.60 | 89.77 | 89.50 | 89.58 | 7332.00 |
| Aug 21, 2024 | 88.85 | 89.17 | 88.77 | 89.12 | 4059.00 |
| Aug 20, 2024 | 86.40 | 86.67 | 86.01 | 86.67 | 2125.00 |
| Aug 19, 2024 | 84.34 | 85.44 | 84.31 | 85.36 | 3782.00 |
| Aug 16, 2024 | 84.22 | 84.93 | 83.95 | 84.93 | 2479.00 |
| Aug 15, 2024 | 83.35 | 84.45 | 83.20 | 84.45 | 4095.00 |
| Aug 14, 2024 | 83.16 | 83.77 | 82.73 | 83.01 | 3915.00 |
| Aug 13, 2024 | 84.05 | 84.84 | 83.98 | 84.84 | 4263.00 |
| Aug 12, 2024 | 83.80 | 84.30 | 83.80 | 83.90 | 3043.00 |
| Aug 09, 2024 | 85.67 | 86.30 | 85.67 | 86.20 | 4139.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
32.45
Minimum
Mar 18 2020
91.57
Maximum
Sep 16 2024
50.28
Average
47.98
Median
May 20 2021
Price Benchmarks
| Galapagos NV | 30.63 |
| Mithra Pharmaceuticals SA | 6.75 |
| Nyxoah SA | 8.26 |
| Celyad Oncology SA | 0.245 |
| MDxHealth SA | 2.55 |
Price Related Metrics
| PE Ratio | 139.41 |
| PS Ratio | 6.091 |
| Price to Book Value | 3.621 |
| Price to Free Cash Flow | 58.38 |
| Earnings Yield | 0.72% |
| Market Cap | 34.75B |
| Operating PE Ratio | 69.79 |
| Normalized PE Ratio | 140.28 |